Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Other solid neoplasm 1

Conditions

Mesothelioma, Malignant 2Solid Tumor, Adult 1Solid Tumor 1Sarcoma 1Retinoblastoma 1Osteosarcoma 1Neoplasm Metastasis 1Mesothelioma 1Lymphoma, Non-Hodgkin 1Lymphoma 1Chondrosarcoma 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1

Interventions

Carboplatin 26Etoposide 22Vincristine 18Melphalan 14Filgrastim 14Topotecan 11Granulocyte Colony-Stimulating Factor 10Cyclophosphamide 9Thiotepa 7Cryotherapy 7Peripheral Blood Stem Cell Transplantation 4Mesna 4Drug Therapy 4Busulfan 4Radiotherapy 3Ifosfamide 3Doxorubicin 3Brachytherapy 3Watchful Waiting 2Temozolomide 2Platinum Compounds 2Magnetic Resonance Imaging 2Eye Enucleation 2Cisplatin 2Blood Specimen Collection 2trioctyl phosphine oxide 1sargramostim 1racotumomab 1pembrolizumab 1pegylated granulocyte colony-stimulating factor 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Retinoblastoma × abemaciclib × Other solid neoplasm × Clear all
NCT04040205 2025-07-20

Abemaciclib for Bone and Soft Tissue Sarcoma With Cyclin-Dependent Kinase (CDK) Pathway Alteration

Medical College of Wisconsin

Phase 2 Recruiting
44 enrolled
Other solid neoplasmSarcoma

Chondrosarcoma, Retinoblastoma, Sarcoma, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡